Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients
Status:
Withdrawn
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to obtain a pharmacokinetic profile (i.e. amount of drug in the
blood over time) of Omecamtiv mecarbil in patients with stable heart failure.